Free Trial

Bristol-Myers Squibb (BMY) SEC Filings & 10K Form

Bristol-Myers Squibb logo
$57.33 +1.03 (+1.83%)
(As of 12/20/2024 05:40 PM ET)

Recent Bristol-Myers Squibb SEC Filings

DateFilerForm TypeView
12/13/2024
3:16 PM
Bristol-Myers Squibb (Filer)
Form S-3ASR
11/05/2024
4:48 PM
Bristol-Myers Squibb (Issuer)
Meyers Gregory Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2024
4:50 PM
Bristol-Myers Squibb (Issuer)
Shanahan Karin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2024
4:53 PM
Bristol-Myers Squibb (Issuer)
Holzer Phil M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2024
4:41 PM
Bristol-Myers Squibb (Issuer)
Hirawat Samit (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2024
4:42 PM
BOERNER CHRISTOPHER S. (Reporting)
Bristol-Myers Squibb (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/04/2024
10:20 AM
Bristol-Myers Squibb (Subject)
Holzer Phil M (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/31/2024
6:52 AM
Bristol-Myers Squibb (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/04/2024
3:20 PM
Bristol-Myers Squibb (Filed by)
Prime Medicine, Inc. (Subject)
Form SC 13G
10/03/2024
5:33 PM
Bristol-Myers Squibb (Issuer)
Gallman Cari (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2024
4:40 PM
Bhatt Deepak (Reporting)
Bristol-Myers Squibb (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2024
4:42 PM
Bristol-Myers Squibb (Issuer)
McMullen Michael R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2024
4:43 PM
Bristol-Myers Squibb (Issuer)
Rice Derica W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2024
4:45 PM
Bristol-Myers Squibb (Issuer)
Samuels Theodore R. II (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2024
4:47 PM
Bristol-Myers Squibb (Issuer)
YALE PHYLLIS R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2024
4:38 PM
Arduini Peter J (Reporting)
Bristol-Myers Squibb (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2024
5:01 PM
Bristol-Myers Squibb (Issuer)
Gallman Cari (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2024
7:12 PM
Bristol-Myers Squibb (Issuer)
McMullen Michael R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2024
7:08 PM
Bristol-Myers Squibb (Issuer)
McMullen Michael R. (Reporting)
Form 3/A
07/26/2024
11:04 AM
Bristol-Myers Squibb (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/26/2024
6:46 AM
Bristol-Myers Squibb (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/02/2024
4:34 PM
Bristol-Myers Squibb (Issuer)
McMullen Michael R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
4:23 PM
Bristol-Myers Squibb (Issuer)
Rice Derica W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
4:25 PM
Bristol-Myers Squibb (Issuer)
Samuels Theodore R. II (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
4:27 PM
Bristol-Myers Squibb (Issuer)
YALE PHYLLIS R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
4:29 PM
Bristol-Myers Squibb (Issuer)
McMullen Michael R. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/02/2024
4:20 PM
Arduini Peter J (Reporting)
Bristol-Myers Squibb (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
4:22 PM
Bhatt Deepak (Reporting)
Bristol-Myers Squibb (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
3:20 PM
Bristol-Myers Squibb (Filer)
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
06/25/2024
3:23 PM
Bristol-Myers Squibb (Filer)
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
06/25/2024
3:24 PM
Bristol-Myers Squibb (Filer)
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
06/18/2024
3:23 PM
Bristol-Myers Squibb (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
3:53 PM
Bristol-Myers Squibb (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/03/2024
5:45 PM
Bristol-Myers Squibb (Issuer)
Lenkowsky Adam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/25/2024
11:38 AM
Bristol-Myers Squibb (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/25/2024
6:47 AM
Bristol-Myers Squibb (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/22/2024
7:16 AM
Bristol-Myers Squibb (Filer)
Form DEFA14A
04/02/2024
5:37 PM
Arduini Peter J (Reporting)
Bristol-Myers Squibb (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
5:38 PM
Bhatt Deepak (Reporting)
Bristol-Myers Squibb (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
5:40 PM
Bristol-Myers Squibb (Issuer)
Rice Derica W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
5:41 PM
Bristol-Myers Squibb (Issuer)
Samuels Theodore R. II (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
$2 Trillion Disappears Because of Fed's Secretive New Move (Ad)

$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being carried out by the Fed that has nothing to do with lowering or raising interest rates... but could soon have an enormous impact on your wealth.

Click here to see his new research now.
04/02/2024
5:43 PM
Bristol-Myers Squibb (Issuer)
Storch Gerald L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
5:44 PM
Bristol-Myers Squibb (Issuer)
YALE PHYLLIS R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
5:45 PM
Bristol-Myers Squibb (Issuer)
Shanahan Karin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2024
4:16 PM
Bristol-Myers Squibb (Filer)
Form DEF 14A
03/28/2024
4:17 PM
Bristol-Myers Squibb (Filer)
Form DEFA14A
03/28/2024
4:19 PM
Bristol-Myers Squibb (Filer)
Form ARS
03/18/2024
4:21 PM
Bristol-Myers Squibb (Filer)
Form PRE 14A
03/18/2024
4:30 PM
Bristol-Myers Squibb (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2024
7:56 AM
Bristol-Myers Squibb (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2024
8:54 PM
Bristol-Myers Squibb (Issuer)
Lenkowsky Adam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
8:43 PM
Bristol-Myers Squibb (Issuer)
LEUNG SANDRA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
8:21 PM
Bristol-Myers Squibb (Issuer)
Plenge Robert M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
8:11 PM
Bristol-Myers Squibb (Issuer)
Poole Ahn Amanda (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
7:40 PM
Bristol-Myers Squibb (Issuer)
Hirawat Samit (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
7:31 PM
Bristol-Myers Squibb (Issuer)
Holzer Phil M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
6:58 PM
BOERNER CHRISTOPHER S. (Reporting)
Bristol-Myers Squibb (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
7:00 PM
Bristol-Myers Squibb (Issuer)
Gallman Cari (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
7:01 PM
Bristol-Myers Squibb (Issuer)
Hoch Lynelle (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
4:46 PM
Bristol-Myers Squibb (Issuer)
Meyers Gregory Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
4:50 PM
Bristol-Myers Squibb (Issuer)
Shanahan Karin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
4:42 PM
Bristol-Myers Squibb (Issuer)
Caforio Giovanni (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
4:43 PM
Bristol-Myers Squibb (Issuer)
Elkins David V (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
4:45 PM
Bristol-Myers Squibb (Issuer)
Hickey Benjamin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
4:52 PM
Bristol-Myers Squibb (Issuer)
Hickey Benjamin (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/23/2024
5:03 PM
Bristol-Myers Squibb (Issuer)
Holzer Phil M (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/23/2024
6:34 AM
Bristol-Myers Squibb (Filed by)
RayzeBio, Inc. (Subject)
Form SC TO-T/A
02/16/2024
3:34 PM
Bristol-Myers Squibb (Filer)
Form 424B5
02/16/2024
10:36 AM
Bristol-Myers Squibb (Filed by)
RayzeBio, Inc. (Subject)
Form SC TO-T/A
02/14/2024
8:07 PM
Bristol-Myers Squibb (Subject)
Form FWP
02/13/2024
10:54 AM
Bristol-Myers Squibb (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/13/2024
7:00 AM
Bristol-Myers Squibb (Filer)
Form 424B2
Transaction specifc information for a delayed shelf offering
02/12/2024
6:34 AM
Bristol-Myers Squibb (Filed by)
RayzeBio, Inc. (Subject)
Form SC TO-T/A
02/05/2024
6:29 PM
Bristol-Myers Squibb (Issuer)
Vousden Karen H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
6:31 PM
Bristol-Myers Squibb (Issuer)
Storch Gerald L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
6:33 PM
Bristol-Myers Squibb (Issuer)
YALE PHYLLIS R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
6:10 PM
Bristol-Myers Squibb (Issuer)
Meyers Gregory Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
6:13 PM
Arduini Peter J (Reporting)
Bristol-Myers Squibb (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
6:15 PM
Bhatt Deepak (Reporting)
Bristol-Myers Squibb (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
6:17 PM
Bristol-Myers Squibb (Issuer)
Haller Julia A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
6:21 PM
Bristol-Myers Squibb (Issuer)
Hidalgo Medina Manuel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
6:24 PM
Bristol-Myers Squibb (Issuer)
Price Paula A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
6:26 PM
Bristol-Myers Squibb (Issuer)
Rice Derica W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
6:27 PM
Bristol-Myers Squibb (Issuer)
Samuels Theodore R. II (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
6:46 AM
Bristol-Myers Squibb (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/25/2024
7:13 AM
Bristol-Myers Squibb (Filed by)
RayzeBio, Inc. (Subject)
Form SC TO-T
01/08/2024
9:29 AM
Bristol-Myers Squibb (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/03/2024
4:48 PM
Bristol-Myers Squibb (Issuer)
Poole Ahn Amanda (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/03/2024
4:38 PM
Bristol-Myers Squibb (Issuer)
Hidalgo Medina Manuel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
4:39 PM
Bristol-Myers Squibb (Issuer)
Rice Derica W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
4:41 PM
Bristol-Myers Squibb (Issuer)
Samuels Theodore R. II (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
$2 Trillion Disappears Because of Fed's Secretive New Move (Ad)

$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being carried out by the Fed that has nothing to do with lowering or raising interest rates... but could soon have an enormous impact on your wealth.

Click here to see his new research now.
01/03/2024
4:42 PM
Bristol-Myers Squibb (Issuer)
Storch Gerald L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
4:44 PM
Bristol-Myers Squibb (Issuer)
YALE PHYLLIS R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
4:31 PM
Arduini Peter J (Reporting)
Bristol-Myers Squibb (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
4:33 PM
Bhatt Deepak (Reporting)
Bristol-Myers Squibb (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
4:36 PM
Bristol-Myers Squibb (Issuer)
Haller Julia A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2023
3:22 PM
Bristol-Myers Squibb (Filed by)
RayzeBio, Inc. (Subject)
Form SC TO-C
12/22/2023
3:36 PM
Bristol-Myers Squibb (Filed by)
Karuna Therapeutics, Inc. (Subject)
Form DFAN14A
12/22/2023
3:21 PM
Bristol-Myers Squibb (Filed by)
Karuna Therapeutics, Inc. (Subject)
Form DFAN14A
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NYSE:BMY) was last updated on 12/23/2024 by MarketBeat.com Staff
From Our Partners